BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/08/2004

FDA Clears Dexamethasone Acetate Injection for Sale, Ends Withdrawal

The US Food and Drug Administration (FDA) has officially determined that DECADRON-LA (dexamethasone acetate injection), 8 mg/mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs) for this medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →